Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women

Psychoneuroendocrinology

Volumn 21, Issue 7, 1996, Pages 575-592

  Klaiber, Edward L ^a   Broverman, Donald M ^b   Vogel, William ^a   Peterson, Linda G ^a   Snyder, Marjorie B ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Worcester State Hospital   (United States)

Author keywords

estrogen; hormonal replacement therapy (HRT); menopause; monoamine oxidase; mood; progestin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ESTRADIOL; ESTROGEN; FOLLITROPIN; GESTAGEN; NORETHISTERONE; PIPERAZINE ESTRONE SULFATE; PLACEBO; TESTOSTERONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MENOPAUSE; MOOD; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTE;

AFFECT; BLOOD PLATELETS; CLIMACTERIC; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); ESTRONE; FEMALE; GONADAL STEROID HORMONES; HUMANS; INDIVIDUALITY; MIDDLE AGED; MONOAMINE OXIDASE; NORETHINDRONE;

EID: 0030267980     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(96)00023-6     Document Type: Article

References (67)

1. Abraham GE (1977) Handbook of radioimmunoassay. In: Clinical and Biochemical Analysis, Vol. 5. Marcel Dekker, New York, pp 591-656.
2. Adolfsson R, Gottfries C-G, Oreland L (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27:1029-1034.
3. Ball P, Knuppen R, Haupt M (1972) Interactions between estrogens and catechol amines: III. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the catechol-o-methyltransferase of human liver. JCEM 34:736-746.
4. Bayard F, Damilano S, Robel P, Baulieu Etienne-Emile (1978) Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium. J Clin Endocrinol Metab 46:635-648.
5. Beck P, Graham LF, Dern E, Jacobsen D, Vitger J, Bolwig TG (1975) Quantitative rating of depression states. Acta Psychiat Scand 51:161-170.
6. Best NR, Rees MP, Barlow DH, Cowen PJ (1992) Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 17:87-93.
7. Cardinali DP, Gomez E (1977) Changes in hypothalamic noradrenaline, dopamine and serotonin uptake after oestradiol administration to rats. J Endocrinol 73:181-182.
8. Clark CL, MacLusky NJ, Parsons B, Naftolin F (1981) Effects of estrogen deprivation on brain estrogen and progestin receptor levels and the activation of female sexual behavior. Horm Behav 15:289-298.
9. Dennerstein L (1987) Depression in the menopause. Obstet Gynecol Clin North Am 4:33-48.
10. Ditkoff EC, Crary WG, Cristo M, Lobo RA (1991) Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78:991-995.
11. Dyrenfurth I, Jewelewicz R, Warren M, Ferin M, VandeWiele RL (1974) Temporal relationships of hormonal variables in the menstrual cycle. In: Ferin M, Halberg F, Richart RM, VandeWiele RL (Eds) Biorhythms and Human Reproduction. John Wiley, New York, pp 171-201.
12. Ehrenkranz JRL (1976) Effects of sex steroids on serotonin uptake in blood platelets. Acta Endocrinol 83:420-428.
13. Elliott JM, Peters JR, Grahame-Smith DG (1980) Oestrogen and progesterone change the binding characteristics of alpha-adrenergic and serotonin receptors on rabbit platelets. Eur J Pharmacol 66:21-30.
14. Eriksson E, Sundblad C, Lisjo P, Modigh K, Andersch B (1992) Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than controls. Psychoneuroendocrinology 17:195-204.
15. Fernandez-Guasti A, Larsson K, Beyer C (1985) Potentiative action of a- and b-adrenergic receptor stimulation in inducing lordosis behavior. Pharmacol Biochem Behav 224:613-617.
16. Fischette CT, Biegon A, McEwen BS (1983) Sex differences in serotonin 1 receptor binding in rat brain. Science 222:333-335.
17. Franz JR, Hull EM, Snyder AM, Roth JA (1978) Effect of maternal progesterone on brain monoamine oxidase activity of neonatal rats. Brain Res 158:397-406.
18. Gereau RW, Kedzie KA, Renner KJ (1993) Effect of progesterone on serotonin turnover in rats primed with estrogen implants into the ventromedial hypothalamus. Brain Res Bull 323:293-300.
19. Grant DA (1956) Analysis-of-variance tests in the analysis and comparison of curves. Psychol Bull 53:141-154.
20. Greengrass PM, Tonge SR (1974) The accumulation of noradrenaline and 5-hydroxytryptamine in three regions of mouse brain after tetrabenazine and iproniazid; Effects of ethinyloestradiol and progesterone. Psychopharmacology 39:187-191.
21. Gudeman JE, Schatzberg AF, Samson JA, Orsulak PJ, Cole JO, Schildkraut JJ (1982) Toward a biochemical classification of depressive disorders VI: Platelet MAO activity and clinical symptoms in depressed patients. Am J Psychiatry 139:630-633.
22. Guicheney P, Leger D, Barrat J (1988) Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: Variations with plasma oestrogen levels and depressive symptoms. Eur J Clin Invest 18:297-304.
23. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr 23:56-62.
24. Hammarback S, Backstrom T, Holst J, von Schoultz B, Lyrenas S (1985) Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestogen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 64:393-397.
25. Hemminki E, Brambilla DJ, McKinlay SM, Posner JG (1991) Use of estrogens among middle-aged Massachusetts women. DICP, Ann Pharmacother 25:418-423.
26. Hemminki E, Kennedy DL, Baum C, McKinlay SM (1988) Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86. Am J Public Health 78:1479-1481.
27. Holsboer F, Benkert O, Demisch L (1983) Changes in MAO activity during estrogen treatment of females with endogenous depression. Modern Probl Pharmacopsychiat 19:321-326.
28. Holst J, Backstrom T, Hammarback S, von Schoultz B (1989) Progestogen addition during oestrogen replacement therapy - effects on vasomotor symptoms and mood. Maturitas 11:13-20.
29. Hyatt MC, Tyce GM (1984) Effects of estradiol on the basal and evoked efflux of norepinephrine and 5-hydroxytryptamine from slides of rat hypothalamus. Life Sci 35:2269-2274.
30. Jacobson L, Riemer RK, Goldfien AC, Lykins D, Siiteri PK, Roberts JM (1987) Rabbit myometrial oxytocin and alpha2-adrenergic receptors are increased by estrogen but are differentially regulated by progesterone. Endocrinology 120:1184-1189.
31. Klaiber EL, Broverman DM, Vogel W (1972) Effects of estrogen therapy on plasma MAO activity and EEG driving responses of depressed women. Am J Psychiatry 128:1492-1498.
32. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y (1979) Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 36:550-554.
33. Klaiber EL, Broverman DM, Vogel W, Kennedy JA, Nadeau CJL (1982) Estrogens and central nervous system function: Electroencephalography, cognition, and depression. In: Friedman RC (Ed) Behavior and the Menstrual cycle. Marcel Dekker, New York, pp 267-289.
34. Klinteberg B, Oreland L, Hallman J (1990) Exploring the connections between platelet monoamine oxidase activity and behavior: Relationships with performance in neuropsychological tasks. Neuropsychobiology 23:188-196.
35. Kobayashi T, Kobayashi T, Kato J, et al. (1966) Cholinergic and adrenergic mechanisms in the female rat hypothalamus with special reference to feedback of ovarian steroid hormones. In: Pincus G, Nakao T, Tait J (Eds) Steroid Dynamics. Academic Press, New York, pp 303-309.
36. Kopin IJ (1966) The role of false transmitters in the action of monoamine oxidase inhibitors. In: Cohen RA (Moderator): Symposium on false neurochemical transmitters. Ann Intern Med 65:359-360.
37. Koster A (1990) Hormone replacement therapy: use patterns in 51-year-old Danish women. Maturitas 10:345-356.
38. Longcope C (1990) Hormone dynamics at the menopause. Ann NY Acad Sci 592:21-30.
39. Mazumder RC, Glover V, Sandler M (1980) Progesterone provokes a selective rise of monoamine oxidase A in female genital tract. Biochem Pharmacol 29:1857-1859.
40. McNair OM, Lorr M, Droppleman LF (1971) Profile of mood states. Educational and Institutional Testing Service, San Diego, CA.
41. Milgrom E, Perrot M, Atger M, Bailieu EE (1972) Progesterone in uterus and plasma. VI. Uterine progesterone receptors during the estrus cycle and implantation in the guinea pig. Endocrinology 90:1071.
42. Murphy DL, Weiss R (1972) Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. Am J Psychiatry 128:1351-1357.
43. Nies A, Robinson DS, Harris LS, et al. (1974) Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives and controls. In: Usdin E. (Ed) Neuropsychopharmacology of Monoamines and Their Regulatory Enzymes. Raven Press, New York.
44. O'Connor LH, Feder HH (1984) Estradiol and progesterone influence a serotonin mediated behavioral syndrome (myoclonus) in female guinea pigs: Comparison with steroid effects on reproductive behavior. Brain Res 293:119-125.
45. Oreland L, Hallman (1988) Monoamine oxidase activity in relation to psychiatric disorders: The state of the art. Nord Psychiat J 42:96-105.
46. Oreland L, Shaskan EG (1983) Monoamine oxidase activity as a biological marker. TIPS August:339-341.
47. Oreland L, Wiberg A, Asberg M (1981) Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Res 4:21-29.
48. Otsuka S, Kobayashi Y (1964) A radioisotopic assay for monoamine oxidase determinations in human plasma. Biochem Pharmacol 13:995-1006.
49. Ottowitz WE, Halbreich U (1995) Mood and cognitive changes following estrogen replacement therapy in postmenopausal women. CNS Drugs 4:161-167.
50. Pearce J, Hawton K, Blake F (1995) Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Br J Psychiat 167:163-173.
51. Raush JL, Parry BL (1993) Treatment of premenstrual mood symptoms. Psychiatr Clin North Am 16:829-839.
52. Renner KJ, Allen DL, Luine VN (1986) Monoamine levels and turnover in brain: Relationship to priming actions of estrogen. Brain Res Bull 164:469-475.
53. Renner KJ, Krey LC, Luine VN (1987) Effect of progesterone on monoamine turnover in the brain of the estrogen-primed rat. Brain Res Bull 192:195-202.
54. Renner KJ, Luine VN (1986) Analysis of temporal and dose-dependent effects of estrogen on monoamines in brain nuclei. Brain Res 366:64-71.
55. Schildkraut J (1965) The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 122:508-522.
56. Sherwin BB (1991) The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. JCEM 72:336-343.
57. Sherwin BB, Gelfand MM (1985) Sex steroids and affect in the surgical menopause: A double-blind, cross-over study. Psychoendocrinology 10:325-335.
58. Sherwin BB, Suranyi-Cadotte BE (1990) Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women. Biol Psychiatry 28:339-348.
59. Spitzer RL, Williams JRW, Gibbon M (1987) Structured Clinical Interview for DSM-III-R Outpatient Version (SCID-OP, 4/1/87). Biometrics Department, New York State Psychiatric Institute, New York.
60. Steiner M, Steinberg S, Stewart D (1995) Fluoxetine in the treatment of premenstrual dysphoria. New Engl J Med 332:1529-1534.
61. Stone AB, Pearlstein TB, Brown WA (1990) Fluoxetine in the treatment of premenstrual syndrome. Psychopharmacol Bull 26:331-335.
62. van Praag HM (1980) Central monoamine metabolism in depressions. I. Serotonin and related compounds. Compr Psychiatry 21:30-43.
63. Vogel W, Broverman DM, Klaiber EL (1971) EEG responses in regularly menstruating women and in amenorrheic women treated with ovarian hormones. Science 172:388-391.
64. von Schoultz B (1986) Climacteric complaints as influenced by progestogens. Maturitas 8:107-112.
65. Wilkinson M, Herdon H, Pearce M, Wilson C (1979) Radioligand binding studies on hypothalamic noradrenergic receptors during the estrous cycle or after steroid injection in ovariectomized rats. Brain Res 168:652-655.
66. Williams J, Uphouse L (1989) Serotonin binding sites during proestrus and following estradiol treatment. Pharmacol Biochem Behav 333:615-620.
67. Wise CD, Potkin SG, Bridge TP, Phelps B, Cannon-Spoor HE, Wyatt RJ (1980) Source of error in the determination of platelet monoamine oxidase. A review of methods. Schizophr Bull 6:245-253.